CTOs on the Move


 
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.my01.io
  • 400 Boul de Maisonneuve Ouest Suite 700
    Montréal, QC CAN H3A 1L4
  • Phone: 855.799.6901

Executives

Name Title Contact Details

Similar Companies

AART

AART is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inari Medical

Inari Medical is a medical device company pioneering devices for the interventional treatment of vascular thrombi and emboli.

Triad Group

Triad Group Inc. is a Hartland, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medscope Communications

Medscope Communications, Inc. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiac Insight

Cardiac Insight, Inc. is a privately held medical device company based in Seattle, WA. Cardiac Insight is developing advanced, body worn ECG sensing technology aimed at the early diagnosis of atrial fibrillation (AF) and other conditions. Earlier last year, the company announced a strategic collaboration with Welch Allyn, now part of the Hill-Rom family of companies, for the distribution rights of certain products and technologies offered by Cardiac Insight.